Ignite Creation Date:
2024-05-06 @ 9:45 AM
Last Modification Date:
2024-10-26 @ 12:19 PM
Study NCT ID:
NCT03063697
Status:
UNKNOWN
Last Update Posted:
2017-02-24
First Post:
2016-05-23
Brief Title:
Observational Study to Evaluate the Safety of DILATREND SR Cap in Korean Patients With Essential Hypertension Chronic Stable Angina and Congestive Heart Failure
Sponsor:
Chong Kun Dang Pharmaceutical
Organization:
Chong Kun Dang Pharmaceutical
Study Overview
Official Title:
Prospective Multi-center Observational Study to Evaluate the Safety of DILATREND SR Cap in Korean Patients With Essential Hypertension Chronic Stable Angina and Congestive Heart Failure
Status:
UNKNOWN
Status Verified Date:
2017-02
Last Known Status:
ENROLLING_BY_INVITATION
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
DELIGHT
Brief Summary:
The purpose of this study is to Evaluate the Safety of DILATREND SR Cap in Korean Patients with Essential hypertension Chronic stable angina and Congestive heart failure for 52 weeks
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None